Waters Corporation

NYSE:WAT

Medical - Diagnostics & Research

Healthcare
$466.10 -0.16%

-$0.57 today

Market cap
$45.81B
Beta
1.20
P/E (TTM)
65.2
EPS (TTM)
$5.47
52W Low $275.05High $414.15

Volume 0.73M

Average 1.03M

WAT Operating Income

Profit from core operations after operating expenses, before interest and taxes.

Waters CorporationNYSE: WAT

Operating Income · Q2 FY2026 · quarter ended Jul 2026

Operating income turns negative

Q2 FY2026 operating income was -$86M, compared with $188.21M a year earlier. Trailing-twelve-month operating income was $369.69M. Over 3 fiscal years it compounded at +0.8% a year.

Context

  • Operating income amounted to 28.2% of revenue in FY2025, up 0.3 pp from a year earlier.
  • Operating income increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether operating income reaches the consensus estimate from 16 analysts of $1.11B (+24.4%) for the fiscal year ending Dec 2026, a step up from the +8.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
-$86M-83.0% QoQ
Last fiscal yearDec 2025
$893.22M+8.1% YoY
LTMJul 2026
$369.69M-56.2% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-145.7%+168.1%+313.8 pp
1 year+8.1%+24.4%+16.3 pp
3-year CAGR+0.8%+15.5%+14.8 pp
5-year CAGR+13.0%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

USD · from the income statement

Latest · FY2025
893.22M USD
Year-over-year change
+8.1%
4-year CAGR
+2.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How WAT compares with its peers on the latest reported figures

  • WAT's LTM Jul 2026 operating income of $369.69M is the 5th highest of the 7 companies compared; the peer median is $1.41B.
  • Its year-over-year change of -56.2% is the lowest of 7, against a peer median of +1.2%.
  • Operating income amounts to 8.0% of revenue for WAT, versus a peer median of 19.2%.
WAT Competitors Peer median
Operating Income for WAT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TMOThermo Fisher Scientific Inc.LTM Sep 2026$8.52B +5.1%-1.7%18.0%
DHRDanaher CorporationLTM Sep 2026$5.22B -2.8%-12.0%20.4%
AAgilent Technologies, Inc.LTM Jul 2026$1.64B +13.5%-2.9%22.2%
MTDMettler-Toledo International Inc.LTM Jun 2026$1.17B +7.0%-0.2%28.4%
WATWaters CorporationLTM Jul 2026$369.69M -56.2%+0.8%8.0%
RVTYRevvity, Inc.LTM Jul 2026$358.85M -9.8%-23.0%12.3%
BRKRBruker CorporationLTM Jun 2026$126.5M -31.2%-18.3%3.6%
Peer median (excluding WAT) $1.41B+1.2%-7.5%19.2%

Competitors are the stored peer set for WAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.79B2.97B2.96B2.96B3.17B
Cost of Revenue1.16B1.25B1.2B1.2B1.34B
Gross Profit1.63B1.72B1.76B1.76B1.83B
Gross Margin58.5%58.0%59.6%59.4%57.8%
Research & Development168.36M176.19M174.95M183.03M195.18M
Selling, General & Admin626.97M658.03M736.01M690.15M740.27M
Operating Expenses807.63M850.38M943.52M931.83M935.45M
Depreciation & Amortization131.68M130.42M165.91M191.83M206.24M
EBITDA982.81M1.02B1B1.04B1.01B
EBITDA Margin35.3%34.2%33.9%35.0%32.0%
Operating Income821.71M873.4M817.68M826.35M893.22M
Operating Margin29.5%29.4%27.7%27.9%28.2%
Interest Income12.22M11.02M16.62M17.42M7.39M
Interest Expense44.94M48.8M98.86M89.68M69.55M
Other Income / Expenses(15.51M)(35.55M)(81.43M)(71.49M)(138.35M)
Income Before Tax806.19M837.85M736.24M754.87M754.88M
Pre-Tax Margin28.9%28.2%24.9%25.5%23.8%
Income Tax Expense113.35M130.09M94.01M117.03M112.25M
Net Income692.84M707.76M642.23M637.83M642.63M
Net Margin24.9%23.8%21.7%21.6%20.3%
EPS (Basic)11.2511.8010.8710.7510.80
EPS (Diluted)11.1711.7310.8410.7110.76
Weighted Avg Shares61.58M59.99M59.08M59.33M59.51M
Weighted Avg Shares (Diluted)62.03M60.33M59.27M59.55M59.71M

Waters Corporation

NYSE:WAT

Intrinsic Alpha fair value

Locked

Current Price

$466.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.